(Q42989056)

English

A relaxed discrimination of 2'-O-methyl-GTP relative to GTP between de novo and Elongative RNA synthesis by the hepatitis C RNA-dependent RNA polymerase NS5B.

scientific article published on 22 November 2004

A Relaxed Discrimination of 2′-O-Methyl-GTP Relative to GTP betweende Novoand Elongative RNA Synthesis by the Hepatitis C RNA-dependent RNA Polymerase NS5B

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

A relaxed discrimination of 2'-O-methyl-GTP relative to GTP between de novo and Elongative RNA synthesis by the hepatitis C RNA-dependent RNA polymerase NS5B. (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

4

object named as

Bruno Canard

1 reference

Europe PubMed Central

12 November 2017

Jean-Claude Guillemot

3

object named as

Jean Claude Guillemot

1 reference

Europe PubMed Central

12 November 2017

author name string

Hélène Dutartre

1

1 reference

Europe PubMed Central

12 November 2017

Joëlle Boretto

2

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

22 November 2004

1 reference

Europe PubMed Central

12 November 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

12 November 2017

280

1 reference

Europe PubMed Central

12 November 2017

8

1 reference

Europe PubMed Central

12 November 2017

6359-6368

1 reference

Europe PubMed Central

12 November 2017

Epidemiology of hepatitis C: geographic differences and temporal trends

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

The relationship between the metabolism of ribavirin and its proposed mechanism of action

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Structural analysis of the activation of ribavirin analogs by NDP kinase: comparison with other ribavirin targets

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Canonical 3'-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Targeting HIV: antiretroviral therapy and development of drug resistance.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Structural determinants and molecular mechanisms for the resistance of HIV-1 RT to nucleoside analogues

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

A mechanism for initiating RNA-dependent RNA polymerization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Structural Analysis of the Hepatitis C Virus RNA Polymerase in Complex with Ribonucleotides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Multiple interactions within the hepatitis C virus RNA polymerase repress primer-dependent RNA synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Enzymatic characterization of the full-length and C-terminally truncated hepatitis C virus RNA polymerases: function of the last 21 amino acids of the C terminus in template binding and RNA synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNA-dependent RNA polymerase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Identification of a C-Terminal Regulatory Motif in Hepatitis C Virus RNA-Dependent RNA Polymerase: Structural and Biochemical Analysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Mechanism of de novo initiation by the hepatitis C virus RNA-dependent RNA polymerase: role of divalent metals

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Selection of 3'-template bases and initiating nucleotides by hepatitis C virus NS5B RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Hepatitis C virus therapies: current treatments, targets and future perspectives

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Targeting NS5B RNA-Dependent RNA Polymerase for Anti-HCV Chemotherapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Template requirements for RNA synthesis by a recombinant hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

De novo initiation of viral RNA-dependent RNA synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Requirements for De Novo Initiation of RNA Synthesis by Recombinant Flaviviral RNA-Dependent RNA Polymerases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410191200

21 January 2018

Identifiers

10.1074/JBC.M410191200

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42989056&oldid=2118713638"